Skip to main content
Erschienen in:

22.05.2024 | Psychiatrie und Psychosomatik | Zertifizierte Fortbildung Psychiatrie

Positronen-Emissions-Tomografie in der Psychiatrie

Mit PET-Bildgebung psychischen Erkrankungen auf der Spur

verfasst von: Univ.-Prof. Dr. med. Irene Neuner, Dr. Ravichandran Rajkumar

Erschienen in: InFo Neurologie + Psychiatrie | Ausgabe 5/2024

zum CME-Kurs Einloggen, um Zugang zu erhalten

Auszug

Die komplexen Zusammenhänge zwischen neurobiologischen Faktoren und psychiatrischen Symptomen sind Gegenstand intensiver Forschung. Durch direkte, quantifizierbare Einblicke in Neurotransmittersysteme, Rezeptordynamik und Hirnstoffwechsel bietet die PET-Bildgebung ein einzigartiges Fenster zu den neurobiologischen Prozessen, die psychischen Erkrankungen zugrunde liegen.
Literatur
1.
Zurück zum Zitat Mayberg HS. Neuroimaging and psychiatry: The long road from bench to bedside. Hastings Cent Rep. 2014; 44: S31-6 Mayberg HS. Neuroimaging and psychiatry: The long road from bench to bedside. Hastings Cent Rep. 2014; 44: S31-6
2.
Zurück zum Zitat Fowler JS et al. PET and drug research and development. J Nucl Med. 1999; 40: 1154 Fowler JS et al. PET and drug research and development. J Nucl Med. 1999; 40: 1154
3.
Zurück zum Zitat Logan J. A review of graphical methods for tracer studies and strategies to reduce bias. Nucl Med Biol. 2003; 30: 833-44 Logan J. A review of graphical methods for tracer studies and strategies to reduce bias. Nucl Med Biol. 2003; 30: 833-44
4.
Zurück zum Zitat Patlak CS et al. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983; 3: 1-7 Patlak CS et al. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983; 3: 1-7
5.
Zurück zum Zitat Ito H et al. A new graphic plot analysis for determination of neuroreceptor binding in positron emission tomography studies. Neuroimage. 2010; 49: 578-86 Ito H et al. A new graphic plot analysis for determination of neuroreceptor binding in positron emission tomography studies. Neuroimage. 2010; 49: 578-86
6.
Zurück zum Zitat Mintun MA et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984; 15: 217-27 Mintun MA et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984; 15: 217-27
7.
Zurück zum Zitat Farde L et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 1986; 231: 258-61 Farde L et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 1986; 231: 258-61
8.
Zurück zum Zitat Howes OD et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012; 69: 776-86 Howes OD et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012; 69: 776-86
9.
Zurück zum Zitat Selvaraj S et al. Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies. Neurosci Biobehav Rev. 2014; 45: 233-45 Selvaraj S et al. Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies. Neurosci Biobehav Rev. 2014; 45: 233-45
10.
Zurück zum Zitat Onwordi EC et al. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun. 2020; 11: 246 Onwordi EC et al. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nat Commun. 2020; 11: 246
11.
Zurück zum Zitat Iliopoulou SM et al. Dopamine and Neuroinflammation in Schizophrenia - Interpreting the Findings from Translocator Protein (18kDa) PET Imaging. Neuropsychiatr Dis Treat. 2021; 17: 3345-57 Iliopoulou SM et al. Dopamine and Neuroinflammation in Schizophrenia - Interpreting the Findings from Translocator Protein (18kDa) PET Imaging. Neuropsychiatr Dis Treat. 2021; 17: 3345-57
12.
Zurück zum Zitat Erritzoe D et al. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge. Biol Psychiatry. 2023; 93: 1089-98 Erritzoe D et al. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge. Biol Psychiatry. 2023; 93: 1089-98
13.
Zurück zum Zitat Kroll T et al. Effects of electroconvulsive therapy on cerebral A1 adenosine receptor availability: a PET study in patients suffering from treatment-resistant major depressive disorder. Front Psychiatry. 2023; 14: 1228438 Kroll T et al. Effects of electroconvulsive therapy on cerebral A1 adenosine receptor availability: a PET study in patients suffering from treatment-resistant major depressive disorder. Front Psychiatry. 2023; 14: 1228438
14.
Zurück zum Zitat Yang X et al. Brain glucose metabolism on [18F]-FDG PET/CT: a dynamic biomarker predicting depression and anxiety in cancer patients. Front Oncol. 2023; 13: 1098943 Yang X et al. Brain glucose metabolism on [18F]-FDG PET/CT: a dynamic biomarker predicting depression and anxiety in cancer patients. Front Oncol. 2023; 13: 1098943
15.
Zurück zum Zitat Wang Y et al. Inflammatory Immune process and depression-like behavior in hypothyroid rats: A [18F] DPA-714 micro positron emission tomography study. Pharmaceuticals (Basel). 2023; 16: 279 Wang Y et al. Inflammatory Immune process and depression-like behavior in hypothyroid rats: A [18F] DPA-714 micro positron emission tomography study. Pharmaceuticals (Basel). 2023; 16: 279
16.
Zurück zum Zitat Slifstein M et al. Detecting pharmacologically induced serotonin release in depression with positron emission tomography imaging: A new approach. Biol Psychiatry. 2023; 93: 1056-8 Slifstein M et al. Detecting pharmacologically induced serotonin release in depression with positron emission tomography imaging: A new approach. Biol Psychiatry. 2023; 93: 1056-8
17.
Zurück zum Zitat Moriguchi S et al. Excess tau PET ligand retention in elderly patients with major depressive disorder. Mol Psychiatry. 2021; 26: 5856-63 Moriguchi S et al. Excess tau PET ligand retention in elderly patients with major depressive disorder. Mol Psychiatry. 2021; 26: 5856-63
18.
Zurück zum Zitat Frick A et al. Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171. Transl Psychiatry. 2015; 5: e597 Frick A et al. Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171. Transl Psychiatry. 2015; 5: e597
19.
Zurück zum Zitat Abadie P et al. Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study. Eur J Neurosci. 1999; 11: 1470-8 Abadie P et al. Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study. Eur J Neurosci. 1999; 11: 1470-8
20.
Zurück zum Zitat Abouzian S et al. Audiovisual intervention alleviates anxiety of patients during PET/CT imaging. Nuklearmedizin. 2022; 61: 301-7 Abouzian S et al. Audiovisual intervention alleviates anxiety of patients during PET/CT imaging. Nuklearmedizin. 2022; 61: 301-7
21.
Zurück zum Zitat Li J et al. Application of PET Imaging in the brain regions of the emotional control loop in patients with generalized anxiety disorder. J Healthc Eng. 2021; 2021: 4505227 Li J et al. Application of PET Imaging in the brain regions of the emotional control loop in patients with generalized anxiety disorder. J Healthc Eng. 2021; 2021: 4505227
22.
Zurück zum Zitat Yatham LN et al. A positron emission tomography study of dopamine transporter density in patients with bipolar disorder with current mania and those with recently remitted mania. JAMA Psychiatry. 2022; 79: 1217-24 Yatham LN et al. A positron emission tomography study of dopamine transporter density in patients with bipolar disorder with current mania and those with recently remitted mania. JAMA Psychiatry. 2022; 79: 1217-24
23.
Zurück zum Zitat Lan MJ et al. Serotonin 1A receptor binding of [11C]CUMI-101 in bipolar depression quantified using positron emission tomography: Relationship to psychopathology and antidepressant response. Int J Neuropsychopharmacol. 2022; 25: 534-44 Lan MJ et al. Serotonin 1A receptor binding of [11C]CUMI-101 in bipolar depression quantified using positron emission tomography: Relationship to psychopathology and antidepressant response. Int J Neuropsychopharmacol. 2022; 25: 534-44
24.
Zurück zum Zitat Wu C et al. Cerebral glucose metabolism in bipolar disorder: A voxel-based meta-analysis of positron emission tomography studies. Brain Behav. 2021; 11: e02117 Wu C et al. Cerebral glucose metabolism in bipolar disorder: A voxel-based meta-analysis of positron emission tomography studies. Brain Behav. 2021; 11: e02117
25.
Zurück zum Zitat Haarman BCMB et al. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study. Brain Behav Immun. 2016; 56: 21-33 Haarman BCMB et al. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study. Brain Behav Immun. 2016; 56: 21-33
26.
Zurück zum Zitat Biria M et al. Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder. Curr Top Behav Neurosci. 2021; 49: 231-68 Biria M et al. Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder. Curr Top Behav Neurosci. 2021; 49: 231-68
27.
Zurück zum Zitat Glorie D et al. Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: A longitudinal [11C]ABP688 PET study. Neuropharmacology. 2020; 177: 108160 Glorie D et al. Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: A longitudinal [11C]ABP688 PET study. Neuropharmacology. 2020; 177: 108160
28.
Zurück zum Zitat Lee J et al. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [11 C]DASB PET study. Hum Psychopharmacol. 2018; 33 Lee J et al. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [11 C]DASB PET study. Hum Psychopharmacol. 2018; 33
29.
Zurück zum Zitat Asch RH et al. Examining mGlu5 Receptor Availability as a Predictor of Vulnerability to PTSD: An [18F]FPEB and PET Study in Male and Female Rats. Chronic Stress (Thousand Oaks). 2023; 7: 24705470231215001 Asch RH et al. Examining mGlu5 Receptor Availability as a Predictor of Vulnerability to PTSD: An [18F]FPEB and PET Study in Male and Female Rats. Chronic Stress (Thousand Oaks). 2023; 7: 24705470231215001
30.
Zurück zum Zitat Neumeister A et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 2013; 18: 1034-40 Neumeister A et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 2013; 18: 1034-40
31.
Zurück zum Zitat Verger A et al. Involvement of the cerebellum in EMDR efficiency: a metabolic connectivity PET study in PTSD. Eur J Psychotraumatol. 2020; 11: 1767986 Verger A et al. Involvement of the cerebellum in EMDR efficiency: a metabolic connectivity PET study in PTSD. Eur J Psychotraumatol. 2020; 11: 1767986
32.
Zurück zum Zitat Fernandez M et al. Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: a positron emission tomography provocation study. Neurosci Lett. 2001; 297: 101-4 Fernandez M et al. Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: a positron emission tomography provocation study. Neurosci Lett. 2001; 297: 101-4
33.
Zurück zum Zitat Liu J et al. Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [18F]FDG PET study. Ann Nucl Med. 2022; 36: 1019-30 Liu J et al. Chronic fluoxetine enhances extinction therapy for PTSD by evaluating brain glucose metabolism in rats: an [18F]FDG PET study. Ann Nucl Med. 2022; 36: 1019-30
34.
Zurück zum Zitat Tollefson S et al. Imaging nociceptin opioid peptide receptors in alcohol use disorder with [11C]NOP-1A and positron emission tomography: Findings from a second cohort. Biol Psychiatry. 2023; 94: 416-23 Tollefson S et al. Imaging nociceptin opioid peptide receptors in alcohol use disorder with [11C]NOP-1A and positron emission tomography: Findings from a second cohort. Biol Psychiatry. 2023; 94: 416-23
35.
Zurück zum Zitat Bralet MC et al. Fluorodeoxyglucose positron emission tomography scans in patients with alcohol use disorder. Alcohol Clin Exp Res. 2022; 46: 994-1010 Bralet MC et al. Fluorodeoxyglucose positron emission tomography scans in patients with alcohol use disorder. Alcohol Clin Exp Res. 2022; 46: 994-1010
36.
Zurück zum Zitat Chukwueke CC et al. Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study. Neuropsychopharmacology. 2021; 46: 2112-20. Chukwueke CC et al. Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study. Neuropsychopharmacology. 2021; 46: 2112-20.
37.
Zurück zum Zitat Flanigan MR et al. Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [11C]PIB PET study. Transl Psychiatry. 2021; 11: 257 Flanigan MR et al. Imaging beta-amyloid (Aβ) burden in the brains of middle-aged individuals with alcohol-use disorders: a [11C]PIB PET study. Transl Psychiatry. 2021; 11: 257
38.
Zurück zum Zitat Best LM et al. Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB. Neuropsychopharmacology. 2020; 45: 1289-96 Best LM et al. Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB. Neuropsychopharmacology. 2020; 45: 1289-96
39.
Zurück zum Zitat Moreno-López L et al. Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. PLoS One. 2012; 7: e39830 Moreno-López L et al. Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. PLoS One. 2012; 7: e39830
40.
Zurück zum Zitat Guerra A Del et al. TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia. Eur Psychiatry. 2018; 50: 7-20. Erratum in: Eur Psychiatry. 2018; 51: 104-5 Guerra A Del et al. TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia. Eur Psychiatry. 2018; 50: 7-20. Erratum in: Eur Psychiatry. 2018; 51: 104-5
41.
Zurück zum Zitat Rajkumar R et al. Excitatory-inhibitory balance within EEG microstates and resting-state fMRI networks: assessed via simultaneous trimodal PET-MR-EEG imaging. Transl Psychiatry. 2021; 11: 60 Rajkumar R et al. Excitatory-inhibitory balance within EEG microstates and resting-state fMRI networks: assessed via simultaneous trimodal PET-MR-EEG imaging. Transl Psychiatry. 2021; 11: 60
42.
Zurück zum Zitat Régio Brambilla C et al. mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [11C]ABP688 PET/MR-EEG. Transl Psychiatry. 2022; 12: 6 Régio Brambilla C et al. mGluR5 binding changes during a mismatch negativity task in a multimodal protocol with [11C]ABP688 PET/MR-EEG. Transl Psychiatry. 2022; 12: 6
43.
Zurück zum Zitat Neuner I et al. Simultaneous PET-MR-EEG: Technology, challenges and application in clinical Neuroscience. IEEE transactions on radiation and plasma medical sciences. 2019; 3: 377-85 Neuner I et al. Simultaneous PET-MR-EEG: Technology, challenges and application in clinical Neuroscience. IEEE transactions on radiation and plasma medical sciences. 2019; 3: 377-85
44.
Zurück zum Zitat Kubota M et al. In vivo PET classification of tau pathologies in patients with frontotemporal dementia. Brain Commun. 2024; 6: fcae075 Kubota M et al. In vivo PET classification of tau pathologies in patients with frontotemporal dementia. Brain Commun. 2024; 6: fcae075
45.
Zurück zum Zitat Zhang Q et al. Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET. Geroscience. 2024; 46: 1407-20 Zhang Q et al. Glucose metabolism in posterior cingulate cortex has supplementary value to predict the progression of cognitively unimpaired to dementia due to Alzheimer's disease: an exploratory study of 18F-FDG-PET. Geroscience. 2024; 46: 1407-20
46.
Zurück zum Zitat Groechel RC et al. Social relationships, amyloid burden, and dementia: The ARIC-PET study. Alzheimers Dement (Amst). 2024; 16: e12560 Groechel RC et al. Social relationships, amyloid burden, and dementia: The ARIC-PET study. Alzheimers Dement (Amst). 2024; 16: e12560
47.
Zurück zum Zitat Huang SH et al. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia. BMC Med Imaging. 2024; 24: 75 Huang SH et al. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia. BMC Med Imaging. 2024; 24: 75
Metadaten
Titel
Positronen-Emissions-Tomografie in der Psychiatrie
Mit PET-Bildgebung psychischen Erkrankungen auf der Spur
verfasst von
Univ.-Prof. Dr. med. Irene Neuner
Dr. Ravichandran Rajkumar
Publikationsdatum
22.05.2024

Weitere Artikel der Ausgabe 5/2024

InFo Neurologie + Psychiatrie 5/2024 Zur Ausgabe